| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGUAUGCAGGUCGCUGCAGGGACCCGAGGCGACACGCGCCUGCAGGAGG… | 3007 nt | 0.5098 | |
| AUUCUGGGGAAGGAGCAGCACCAAAUCCAAGAUGGCGGCCAGCAGGAGG… | 2765 nt | 0.5005 | |
| AUUCUGGGGAAGGAGCAGCACCAAAUCCAAGAUGGCGGCCAGCAGGAGG… | 2861 nt | 0.4974 |
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to participate in the ubiquitination of p53, c-Fos, and the NF-kB precursor p105 in vitro. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]
A study in mice demonstrated that chronic methamphetamine administration significantly dysregulates the UBE2L3 in cortical microglia, as part of widespread disruptions to ubiquitin-mediated proteolysis, autophagy, and mitophagy pathways revealed by single-cell RNA sequencing [Oladapo et al. DOI:10.3390/Ijms26020649]. A study in human postmortem brain tissue demonstrated that the UBE2L3 is up-regulated in both the frontal and motor cortices of alcoholic cases compared to controls, as identified through cDNA microarray profiling and validated by Bayesian statistical analysis and hierarchical clustering [Liu et al. DOI:10.1111/J.1471-4159.2004.02570.X]. Separately, research on degraded forensic samples established that targeting transcript stable regions (StaRs) with specifically designed primers enables the consistent and specific detection of RNA biomarkers, including related ubiquitin-conjugating enzymes, across various degraded body fluids for identification purposes [Lin et al. DOI:10.1016/j.fsigen.2015.09.012].